#ASH17 Live Blog

Our Mayo Clinic colleagues are in Atlanta for the 59th American Society of Hematology Annual Meeting & Exhibition. Follow this blog for live updates from #ASH17 as we attend the conference, mingle with colleagues at booth #2123, and have a little fun. Have a comment or photo to share? Send it to us on Twitter (@MayoClinicLabs) or Facebook.

Dec. 11 at 10:37 a.m. EST

See You in San Diego!

The exhibit hall is closed, and we are wrapping up our activities in Atlanta. Thank you so much to our symposium presenters, in-booth speakers, physicians, scientists, and allied health staff. Thanks for a great #ASH17. We are already looking forward to #ASH18! #warmweatherplease

Dec. 11 at 10:37 a.m. EST

#ASH17 In-Booth Presentation: Linda Baughn, Ph.D.

Yesterday, Linda Baughn, Ph.D., capped off our in-booth presentation series with, "Mate-Pair Sequencing to Characterize Chromosome Rearrangements In Neoplasia." The presentation was broadcast live on Facebook, and the archived version is now available:


Dec. 10 at 6:47 p.m. EST

Moving the Science Forward

At this year's ASH, a number of Mayo Clinic physicians, scientists, fellows, residents, and allied health staff delivered more than 100 abstract presentations on Saturday and Sunday evening. Congratulations to our colleagues for this great honor.

A Mayo Clinic author discusses his findings with a peer.

Dec. 10 at 3:38 p.m. EST

#ASH17 In-Booth Presentation: Patricia Greipp, D.O.

Dr. Patricia Greipp was second on the docket for today's in-booth presentations. Her talk, "Ph-Like B-ALL—Diagnostic Cytogenetics: An Algorithmic Approach," was live-cast on Facebook, and the archived version is now available:

Dec. 10 at 2:25 p.m. EST

#ASH17 In-Booth Presentation: Daniel VanDyke, Ph.D.

Dr. Daniel VanDyke's presentation, entitled, "MDS & AML: Chromosomes, Yes; FISH, No.," was live-cast on Facebook, and the archived version is now available:

Dec. 10 at 11:15 a.m. EST

#ASH17 Audio Insights with Daniel VanDyke, Ph.D.

This morning's exhibit session kicked off with an in-booth presentation from Dr. Daniel VanDyke. After his presentation, which we will post later today, he sat down with us to provide a brief overview:

Dec. 10 at 9:08 a.m. EST

#ASH17 Audio Insights with Dragan Jevremovic, M.D., Ph.D.

After Friday morning's symposium, we were able to catch up with Dr. Dragan Jevremovic who talked about the presentation he gave in collaboration with Francis Buadi, M.D.:

Dec. 9 at 6:17 p.m. EST

International Research Team Identifies Genetic-Based Model for Predicting Outcomes in Primary Myelofibrosis

A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease. The group’s findings were presented today at the 59th American Society of Hematology annual meeting in Atlanta by lead authors Alessandro Vannucchi, M.D., from the University of Florence and Ayalew Tefferi, M.D., a hematologist at Mayo Clinic.

Read the full article.

Dec. 9 at 6:05 p.m. EST

#ASH17 In-Booth Presentation: Rajiv Pruthi, M.B.B.S.

Dr. Rajiv Pruthi's presentation, entitled, "APC-R vs. Factor V Leiden Testing," was live-cast on Facebook.
Unfortunately, we experienced technical difficulties with the in-booth audio system, which led to the video having poor audio quality. As such, we are unable to post it, but have added Dr. Pruthi's presentation slides instead. Our apologies for this inconvenience.

Dec. 9 at 5:40 p.m. EST

#ASH17 Audio Insights with Rajiv Pruthi, M.B.B.S.

On Saturday morning, Rajiv Pruthi, M.B.B.S., delivered a brief presentation in our exhibit titled, "APC-R vs. Factor V Leiden Testing." After his presentation, we were able to speak with him for a quick overview:

Dec. 9 at 4:35 p.m. EST

Mayo Clinic Study Finds Emojis Promising Tool for Tracking Cancer Patients’ Quality of Life

In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of traditional emotional scales were helpful in assessing patients’ physical, emotional, and overall quality of life. Researchers found that using iPhones and Apple watches were favored by patients, and the technology helped collect study data accurately and efficiently.

Read the full article.

Dec. 9 at 3:05 p.m. EST

#ASH17 In-Booth Presentation: Ellen McPhail, M.D.

Dr. Ellen McPhail's presentation, entitled, "Amyloid Protein Identification by Mass Spectrometry," was live-cast on Facebook, and the archived version is now available:

Dec. 9 at 2:27 p.m. EST

#ASH17 Audio Insights with Ellen McPhail, M.D.

After delivering two presentations in as many days, we were lucky enough to catch up with Ellen McPhail, M.D., who gave us quick overviews of her presentations:

Dec. 9 at 11:07 a.m. EST

Mayo Medical Laboratories Pre-Conference Symposium

Course faculty, pictured from left to right: Dong Chen, M.D., Ph.D.; Kaaren Reichard, M.D.; Dragan Jevremovic, M.D., Ph.D.; Ellen McPhail, M.D.; Francis Buadi, M.D.; Rajiv Pruthi, M.B.B.S.; and David Viswanatha, M.D.

Our Satellite Symposium preceding the 59th ASH Annual Meeting, Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration, was held yesterday morning. With a variety of presentations and discussion, the symposium is designed to update the practicing hematologists/oncologists and hematopathologists about the evolving repertoire of test options and appropriate testing strategies.

Participants had the opportunity to hear from our renowned faculty and enjoy the following presentations:

  • Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Update Per the 2016 Revision of the WHO Classification of Lymphoid Neoplasms
  • Next-Generation Sequencing Testing in Myeloid Malignancies: AML
    and Chronic Myelomonocytic Leukemia Case Examples
  • Eosinophilia Optimizing Test Utilization in the Bone Marrow Workup
  • Algorithmic Approach in the Diagnosis and Treatment
    of Multiple Myeloma
Mrinal Patnaik, M.B.B.S., discusses differentiation of myeloblasts with enasidenib during his presentation.
The room, moments before the doors were opened.
Mayo Clinic Laboratories (@mayocliniclabs)

Mayo Clinic Laboratories

This post was authored by the Marketing Team at Mayo Clinic Laboratories.